Notice of Intent to Sole Source – Cardinal Health, Inc.

Back Print
Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
State: Maryland
Level of Government: Federal
Category:
  • Q - Medical Services
Opps ID: NBD00159210101458822
Posted Date: Apr 10, 2024
Due Date: Apr 25, 2024
Solicitation No: 24-006053
Source: Members Only
Follow
Notice of Intent to Sole Source – Cardinal Health, Inc.
Active
Contract Opportunity
Notice ID
24-006053
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH - CC
General Information
  • Contract Opportunity Type: Special Notice (Original)
  • All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Original Published Date: Apr 10, 2024 02:35 pm EDT
  • Original Response Date: Apr 25, 2024 01:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: May 10, 2024
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: Q509 - MEDICAL- INTERNAL MEDICINE
  • NAICS Code:
    • 424210 - Drugs and Druggists' Sundries Merchant Wholesalers
  • Place of Performance:
    Bethesda , MD
    USA
Description

Floxuridine vials for injection for the NIH Clinical Center (CC)




  • Product Service Code: Q509

  • NAICS Code: 424210

  • Place of Performance: Bethesda, MD 20892





POTS: 24-006053





Description





This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.





The National Institutes of Health (NIH) intends to award a fixed price purchase order to: Cardinal Health, Inc. located at 7000 Cardinal Pl, Dublin, OH 43017 on a firm fixed price sole source award basis to provide 10 each vials of Floxuridine for injection.





The below items are required for this action:





Catalog Number Description Quantity



0143-9270-01 Floxuridine for Injection 10





This supply is needed for planned patient care at the National Institutes of Health, Clinical Center and is distributed in the United States only by the proposed vendor.





This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.





Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.





Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to kristin.nagashima@nih.gov by the due date April 25, 2024 and time marked in this notice


Attachments/Links
Contact Information
Contracting Office Address
  • 6707 DEMOCRACY BLVD, SUITE 106
  • BETHESDA , MD 20892
  • USA
Primary Point of Contact
Secondary Point of Contact


History
  • Apr 10, 2024 02:35 pm EDTSpecial Notice (Original)

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >